| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $2.4M | +106.7% |
| Operating Income | -$2.4M | -91.8% |
| Pre-tax Income | -$2.4M | -91.8% |
| Income Tax | $0 | — |
| Net Income | -$2.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $895K | -71.1% |
| Current Assets | $1.0M | -69.5% |
| Total Assets | $1.5M | -54.1% |
| Current Liabilities | $114K | -5.3% |
| Stockholders' Equity | $1.4M | -55.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | -44.2% |
| Capital Expenditures | $3K | -30.8% |
| Investing Cash Flow | -$3K | +30.8% |
| Financing Cash Flow | -$425K | -177.3% |
| Free Cash Flow | -$1.8M | -43.9% |
| EPS (Basic) | -$0.72 | -148.3% |
| EPS (Diluted) | -$0.72 | -132.3% |